Eli Lilly’s orforglipron could offer needle-free alternative to weight-loss jabs at lower cost

Researchers found Ozempic-induced weight loss decreased muscle mass by about 10 per cent

In an 18-month clinical trial of the experimental GLP-1 pill orforglipron, about 60 percent of people lost at least 10 percent of their body weight.